FDA Inspection
Biomat USA Inc (Birmingham Location #2)Biomat USA Inc (Birmingham Location #2) – FDA Inspection, Mar 30, 2012
Record Details
This FDA Inspection record concerns Biomat USA Inc (Birmingham Location #2), with an inspection on March 30, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- March 30, 2012
- Product Type
- Biologics
View Company Profile
ID · 1a17fb57-e765-442d-8e74-ce9104174dc9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 774401
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.160(a)(1)Concurrent documentation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Biomat USA Inc (Birmingham Location #2)
4| Date | Classification | Office | Project area |
|---|---|---|---|
| January 16, 2020 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 25, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 25, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 13, 2009 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Biomat USA Inc (Birmingham Location #2)
- FDA Inspection 1119126 - 2020-01-16
- FDA Inspection 1008953 - 2017-04-25
- FDA Inspection 932135 - 2015-06-25
- FDA Inspection 569284 - 2009-03-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.